Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable Device

NCT04969848 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2022-06-03

No results posted yet for this study

Summary

Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. The development of wearable device offers the opportunity to collect data during daily activity including walking.

Conditions

Interventions

OTHER

Wearable sensor

IMU sensor (as part of eMSGait device) worn at the hip during T25FW

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-18
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04969848 on ClinicalTrials.gov